Liquid Biopsy perspectives theranostics and personalized oncology
Open Access
- 14 September 2020
- journal article
- research article
- Published by Peertechz Publications Private Limited in Annals of Cytology and Pathology
- Vol. 5 (1) , 073-077
Abstract
The current limitations of cancer diagnosis and molecular profiling based on invasive tissue biopsies or clinical imaging have led to the development of the Liquid Biopsy field (LB),Keywords
This publication has 24 references indexed in Scilit:
- Clinical utility of circulating non-coding RNAs — an updateNature Reviews Clinical Oncology, 2018
- Liquid Biopsy in Tumor Genetic DiagnosisDeutsches Ärzteblatt international, 2018
- Liquid biopsy: unlocking the potentials of cell-free DNAVirchows Archiv, 2017
- Liquid biopsies come of age: towards implementation of circulating tumour DNANature Reviews Cancer, 2017
- Liquid Biopsies, What We Do Not Know (Yet)Cancer Cell, 2017
- Clonal Heterogeneity and Tumor Evolution: Past, Present, and the FutureCell, 2017
- Origins, structures, and functions of circulating DNA in oncologyCancer and Metastasis Reviews, 2016
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid BiopsyCancer Discovery, 2016
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The cancer genomeNature, 2009